Cargando…
MUS81 Inhibition Enhances the Anticancer Efficacy of Talazoparib by Impairing ATR/CHK1 Signaling Pathway in Gastric Cancer
MUS81 is a critical endonuclease involved in heterodimer formation with Eme1/Mms4 and an important DNA damage repair regulatory molecule. Our previous study suggested that MUS81 was overexpressed and its high expression was positively correlated with gastric cancer metastasis. However, the therapeut...
Autores principales: | Wang, Tao, Zhang, Peng, Li, Chengguo, Liu, Weizhen, Shen, Qian, Yang, Lei, Xie, Gengchen, Bai, Jie, Li, Ruidong, Tao, Kaixiong, Yin, Yuping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035870/ https://www.ncbi.nlm.nih.gov/pubmed/35480096 http://dx.doi.org/10.3389/fonc.2022.844135 |
Ejemplares similares
-
Targeting MUS81 promotes the anticancer effect of WEE1 inhibitor and immune checkpoint blocking combination therapy via activating cGAS/STING signaling in gastric cancer cells
por: Li, Chengguo, et al.
Publicado: (2021) -
Inactivation of Chk2 and Mus81 Leads to Impaired Lymphocytes Development, Reduced Genomic Instability, and Suppression of Cancer
por: El Ghamrasni, Samah, et al.
Publicado: (2011) -
MicroRNA-152 regulates immune response via targeting B7-H1 in gastric carcinoma
por: Wang, Yaxin, et al.
Publicado: (2017) -
Mus81 knockdown improves chemosensitivity of hepatocellular carcinoma cells by inducing S‐phase arrest and promoting apoptosis through CHK1 pathway
por: Wu, Fan, et al.
Publicado: (2015) -
Combination of PARP inhibitor and CDK4/6 inhibitor modulates cGAS/STING‐dependent therapy‐induced senescence and provides “one‐two punch” opportunity with anti‐PD‐L1 therapy in colorectal cancer
por: Wang, Tao, et al.
Publicado: (2023)